Stem Cell Research Act 2025 (H.R. 5160)

Summary

Keeps funding a program for stem cell transplants and another for storing umbilical cord blood, helping to treat many serious diseases.

What problem does this solve?

Federal support for stem cell therapy and cord blood collection programs was going to end, stopping important medical research and treatments. This bill provides new money and extends the programs until 2031, allowing them to keep helping people with serious illnesses.

What does this bill do?

Funds the C.W. Bill Young Cell Transplantation Program

Provides $33,009,000 for each fiscal year from 2027 through 2031 to support the cell transplantation program.

Extends the national cord blood inventory

Changes the end date for the national cord blood inventory program from 2026 to 2031, allowing it to continue for five more years.

Who does this affect?

Patients needing stem cell transplants
Medical researchers
Hospitals and transplant centers

What is the real world impact?

•

Continues life-saving medical programs

Keeps important medical programs running that use stem cells and cord blood to treat serious diseases. The goal is to make sure these treatments and research efforts don't stop because of a lack of money.

When does this start?

This bill outlines funding and program timelines that begin in 2027 and end in 2031.

Cell transplantation program funding

Funding of $33,009,000 is authorized for each fiscal year from 2027 through 2031.

Cord blood inventory extension

The authority for the cord blood inventory program is extended to 2031.